1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Europe Market by Product 43
3.1 Market Overview by Product 43
3.2 Instruments & Devices 45
3.2.1 Disposable IVD Devices 46
3.2.2 Reusable IVD Devices 47
3.3 Reagents & Kits 48
3.4 Software & Services 49
4 Segmentation of Europe Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Clinical Chemistry 52
4.3 Molecular Diagnostics 53
4.4 Immuno Diagnostics 54
4.5 Hematology 55
4.6 Tissue Diagnostics 56
4.7 Microbiology 57
4.8 Coagulation and Hemostasis 58
4.9 Urinalysis 59
4.10 Other Technologies 60
5 Segmentation of Europe Market by Sample Type 61
5.1 Market Overview by Sample Type 61
5.2 Blood 63
5.3 Mucus 64
5.4 Urine 65
5.5 Other Sample Types 66
6 Segmentation of Europe Market by Application 67
6.1 Market Overview by Application 67
6.2 Infectious Diseases 69
6.3 Diabetes 79
6.4 Cancer/Oncology 80
6.5 Cardiology 81
6.6 Autoimmune Disease 82
6.7 Nephrology 83
6.8 Drug Testing 84
6.9 HIV/AIDS 85
6.10 Other Applications 86
7 Segmentation of Europe Market by End User 87
7.1 Market Overview by End User 87
7.2 Diagnostic Laboratories 89
7.3 Hospitals and Clinics 90
7.4 Homecare Settings 91
7.5 Point-of-Care (POC) Settings 92
7.6 Other End Users 93
8 European Market 2021-2031 by Country 94
8.1 Overview of European Market 94
8.2 Germany 97
8.3 U.K. 99
8.4 France 101
8.5 Spain 103
8.6 Italy 105
8.7 Netherlands 107
8.8 Rest of European Market 109
9 Competitive Landscape 111
9.1 Overview of Key Vendors 111
9.2 New Product Launch, Partnership, Investment, and M&A 114
9.3 Company Profiles 115
Abbott Laboratories, Inc. 115
Agilent Technologies, Inc. 117
Arkray Inc. 118
Becton, Dickinson and Company 119
Biomerieux SA 120
Bio-Rad Laboratories Inc. 121
Danaher Corporation 122
DiaSorin SpA (Luminex Corporation) 123
Epic Systems Corporation 124
F. Hoffmann-La Roche Ltd. 125
Genpact Limited 126
Grifols SA 127
IBM Corporation 128
Mckesson Corporation 129
Ortho Clinical Diagnostics Inc. 130
Qiagen NV 131
Quest Diagnostics Inc. 132
Quidel Corporation 133
Roche Diagnostics 134
Siemens Healthineers 135
Sysmex Corporation 136
Thermo Fisher Scientific Inc. 137
RELATED REPORTS 138